SCHEMBL4673259

SCHEMBL4673259

O=C(O)C(O)=CC(=O)c1cc(Sc2ccccc2)c[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.41
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
NCOA1 Q15788 1/20 0.31
NCOA3 Q9Y6Q9 1/20 0.31
BCL2 P10415 1/20 0.31
SIRT1 Q96EB6 2/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31
TUBA3C P0DPH7 1/20 0.31
TUBA1B P68363 1/20 0.31
TUBA4A P68366 1/20 0.31
TUBB4B P68371 1/20 0.31
TUBB3 Q13509 1/20 0.31
TUBB2A Q13885 1/20 0.31
TUBB8 Q3ZCM7 1/20 0.31
TUBA3E Q6PEY2 1/20 0.31
TUBA1A Q71U36 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673256 1.00 MCL1 (0.41) MCL1ALDH1A1HPGDMAOAMAOB
SCHEMBL10940113 0.79 MCL1 (0.49) MCL1ALDH1A1HPGDMAOAMAOB
SCHEMBL4676418 0.75 ALDH1A1 (0.35) MCL1ALDH1A1HPGDSIRT1TUBB4A
SCHEMBL4676420 0.75 ALDH1A1 (0.35) MCL1ALDH1A1HPGDSIRT1TUBB4A
SCHEMBL4671103 0.75 ALDH1A1 (0.33) ALDH1A1HPGDSIRT1TUBB4ATUBB
SCHEMBL4671100 0.75 ALDH1A1 (0.33) ALDH1A1HPGDSIRT1TUBB4ATUBB
SCHEMBL4677585 0.74 NOTUM (0.35) ALDH1A1HPGDNCOA1NCOA3MAPT
SCHEMBL4675566 0.73 GAA (0.39) ALDH1A1LMNAGAARAB9A
SCHEMBL4675568 0.73 GAA (0.39) ALDH1A1LMNAGAARAB9A
SCHEMBL4672654 0.72 HTR6 (0.40) ALDH1A1HPGDLMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 MCL1 1362/4885ALDH1A1 980/4885HPGD 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.